Welcome to our dedicated page for Nordson news (Ticker: NDSN), a resource for investors and traders seeking the latest updates and insights on Nordson stock.
Nordson Corporation (NASDAQ: NDSN) is a precision technology and manufacturing company that reports detailed financial and operational updates across its Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions segments. This news page aggregates Nordson-related announcements so readers can follow developments that affect the company’s operations, strategy and NDSN stock.
Visitors can review earnings releases that outline segment sales, EBITDA, free cash flow and guidance, including commentary on organic growth, acquisition impacts and currency effects. Nordson’s news also covers Board decisions such as dividend declarations, dividend increases and share repurchase authorizations, which illustrate the company’s capital allocation priorities and long record of annual dividend growth.
Because Nordson serves diverse end markets in packaging, nonwovens, electronics, medical, appliances, energy, transportation, building and construction, and general product assembly and finishing, its news flow includes product and technology updates from businesses like Nordson EFD and Nordson MEDICAL. These releases describe precision fluid dispensing systems, medical component technologies and applications at industry events, as well as portfolio actions such as the divestiture of select medical contract manufacturing product lines.
Corporate responsibility and governance updates, including Nordson’s Corporate Responsibility Update and disclosures about executive policies, also appear in the company’s news. By monitoring this page, investors and industry observers can track how Nordson’s segment performance, global activities, portfolio decisions and governance practices evolve over time and how these developments relate to the NDSN share listing on Nasdaq.
Nordson Electronics Solutions has consolidated its European operations into a new state-of-the-art facility in Valkenswaard, The Netherlands. This move integrates multiple sites from Deurne, Maastricht, and Hagenbach, Germany, into a central location to meet rising European customer demand. The new facility features a demonstration lab showcasing the latest equipment from ASYMTEK, MARCH, and SELECT product lines, offering solutions for conformal coating, fluid dispensing, plasma treatment, and selective soldering in electronics manufacturing.
The modern building incorporates environmental efficiency features such as solar panels and energy-conserving underfloor heating, aligning with Nordson 's sustainability commitment. Located in the Eindhoven area, the new site minimizes disruption to customers, partners, and suppliers while supporting customers backed by the European Chips Act to boost regional resilience.
Nordson (Nasdaq: NDSN) announced its agreement to acquire Atrion (Nasdaq: ATRI), a leader in medical infusion and cardiovascular technologies, for $460.00 per share in cash. This acquisition values Atrion at approximately $800 million and expands Nordson’s medical portfolio into new markets and therapies. Atrion generated about $169 million in revenue in 2023 and operates three FDA registered manufacturing facilities in the U.S.
The acquisition will be funded through cash on hand and newly issued financial debt and is expected to close before Nordson’s fiscal year-end in 2024, pending regulatory and stockholder approvals. The transaction is expected to generate significant synergies within the first two years of ownership.
The acquisition aligns with Nordson's strategy to leverage long-term growth drivers in the medical sector, including an aging population, increased healthcare spending, and the adoption of minimally invasive surgical techniques.
Nordson (Nasdaq: NDSN) reported its fiscal Q2 2024 results with sales of $651 million, matching last year's figure. Net income stood at $118 million, equating to $2.05 per diluted share, a slight decrease from the previous year's $128 million and $2.21 per share. Adjusted earnings were $2.34 per share, down from $2.45. EBITDA remained flat at $203 million, representing 31% of sales.
Segment-wise, Industrial Precision Solutions saw a 9% sales increase to $367 million, while Medical and Fluid Solutions experienced a 2% rise to $169 million. Advanced Technology Solutions, however, faced a 22% decline in sales to $115 million.
Nordson updated its full-year fiscal 2024 guidance to forecast flat to 2% revenue growth, with adjusted EPS expected to range between $9.35 and $9.75. Q3 sales are projected between $645 and $670 million, with adjusted EPS of $2.25 to $2.40.
Nordson (Nasdaq: NDSN) declared a third quarter cash dividend of $0.68 per share for fiscal year 2024, maintaining the same amount as the previous quarter. The company is known for its innovative precision technology and diverse end market exposure, including consumer non-durable, medical, electronics, and industrial markets.
Nordson (Nasdaq: NDSN) announced the release of its second-quarter fiscal year 2024 earnings on May 20, 2024. The company will host a webcast on May 21, 2024, at 8:30 AM ET. Nordson is a precision technology company with a direct sales model, serving global customers in various end markets.
FAQ
What is the current stock price of Nordson (NDSN)?
What is the market cap of Nordson (NDSN)?
